Socket Augmentation Using Atorvastatin With Or Without PRGF (Clinical and Histomorphometric Study)

• Status: Completed
• Trial end date: 2018-08-15
• Target enrollment: 0
• Participant gender: All

Summary

Despite the numerous studies describing the benefits of PRGF (plasma rich in growth factors) and Statins separately , there has been a lack of clinical investigation into the simultaneous use of these agents in socket augmentation. Therefore the main objective of this study is to evaluate socket bone dimensions and quality following the use of PRGF derived fibrin scaffold as a carrier for Atorvastatin in socket augmentation clinically and histomorphometrically.

• Phase: Phase 4
• Accepts Healthy Volunteers?: Accepts Healthy Volunteers

Details

• Lead Sponsor: Ain Shams University
• Treatments: Atorvastatin; Atorvastatin Calcium; Mitogens

Criteria

Inclusion Criteria:

• Healthy adult patients as evidenced by Burkett's oral medicine health history questionnaire.

• Both sexes.

• Age from 20 - 50 years old.

• Having at least one hopeless tooth indicated for extraction.

• Patient should agree to sign a written consent after the nature of the study will be explained.

Exclusion Criteria:

• Smokers.

• Pregnant and breast feeding females.

• Prisoners and handicapped patients.